医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

The 2nd meeting of the Bridging Biomedical Worlds series: “From Neural Circuitry to Neurotechnology”

2015年05月11日 AM08:00
このエントリーをはてなブックマークに追加


 

PARIS

Neural circuits are central to our understanding of how the brain works. Promoting basic research into the form and function of neural circuits and the translation of this research into neurotechnologies for both studying the brain and for treating different diseases and injuries is the theme of our 2015 Bridging Biomedical Worlds conference.

This conference, From Neural Circuitry to Neurotechnology, will be held in Tokyo, Japan, in May 11-12, 2015, and is jointly organized by Fondation IPSEN, AAAS/Science and AAAS/Science Translational Medicine, and the RIKEN Brain Science Institute. The meeting will cover a broad range of topics including memory formation, decision making, sensory systems, circuits that determine complex behavior, and new technologies that exploit neural circuitry, as well as the translation of this knowledge into clinical applications.

About AAAS/Science

The American Association for the Advancement of Science (AAAS) is the world’s largest general scientific society and publisher of the journal Science (www.sciencemag.org) as well as Science Translational Medicine (www.sciencetranslationalmedicine.org), Science Signaling (www.sciencesignaling.org), and Science Advances (http://advances.sciencemag.org/). AAAS was founded in 1848, and includes some 261 affiliated societies and academies of science, serving 10 million individuals. Science has the largest paid circulation of any peer-reviewed general science journal in the world, with an estimated total readership of 1 million. The non-profit AAAS (www.aaas.org) is open to all and fulfills its mission to “advance science and serve society” not only by publishing the very best scientific research but also through initiatives in science policy, international programs and science education.

www.sciencemag.org

About AAAS/Science Translational Medicine

Science Translational Medicine was launched in October 2009. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest biomedical research findings from basic, translational, and clinical researchers from all established and emerging disciplines relevant to medicine. Despite 50 years of advances in our fundamental understanding of human biology and the emergence of powerful new technologies, the translation of this knowledge into effective new treatments and health measures has been slow. This paradox illustrates the daunting complexity of the challenges faced by translational researchers as they apply the basic discoveries and experimental approaches of modern science to the alleviation of human suffering. A major goal of Science Translational Medicine is to publish papers that identify and fill the scientific knowledge gaps at the junction of basic research and medical application in order to accelerate the translation of scientific knowledge into new methods for preventing, diagnosing and treating human disease.

www.sciencetranslationalmedicine.org

About the RIKEN Brain Science Institute

RIKEN is Japan’s largest research institute covering a broad spectrum of fundamental and applied disciplines including physics, chemistry, biology, engineering, and medical sciences. RIKEN’s emphasis on interdisciplinary collaboration, societal application, and globalization has earned a worldwide reputation for excellence. As one of RIKEN’s flagship centers, the Brain Science Institute (BSI) conducts cutting-edge neuroscience research to understand brain function from molecules to neural circuits to cognition, drawing on methods from a range of disciplines. Close to the Tokyo metropolis and with English as the official language, BSI serves as an international hub for research innovation in Japan with career development opportunities for postdoctoral fellows and graduate students.

http://www.brain.riken.jp/en/

About the Fondation Ipsen

Established in 1983 under the aegis of the Fondation de France, the mission of the Fondation Ipsen is to contribute to the development and dissemination of scientific knowledge. The long-standing action of the Fondation Ipsen aims at fostering the interaction between researchers and clinical practitioners, which is essential due to the extreme specialization of these professions. The ambition of the Fondation Ipsen is to initiate a reflection about the major scientific issues of the forthcoming years. It has developed an important international network of scientific experts who meet regularly at meetings known as Colloques Médecine et Recherche, dedicated to five main themes: Alzheimer’s disease, neurosciences, longevity, endocrinology and cancer science. Moreover the Fondation Ipsen has started since 2007 several meetings in partnership with the Salk Institute, the Karolinska Institutet, the Massachusetts General Hospital, the Days of Molecular Medicine Global Foundation as well as with the science journals Nature, Cell and Science. The Fondation Ipsen has published over one hundred books and has awarded more than 250 prizes and research grants.

www.fondation-ipsen.org

CONTACT

For further information, please contact:
Isabelle de
Segonzac, Image Sept
E-mail : isegonzac@image7.fr
Tel.
: +33 (0)1 53 70 74 70

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • Bristol-Myers Squibb Granted Exclusive License by Ono Pharmaceutical for Multiple Programs Targeting Immuno-Suppressive Factors in the Tumor Microenvironment
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表
  • Vedanta Biosciences Granted Four New U.S. Patents Expanding Coverage for Compositions and Methods of Use for Therapeutics Based on Microbiome-Derived Bacterial Consortia
  • Daiichi Sankyo and Puma Biotechnology Announce Research Collaboration with Major Cancer Center in HER2-Mutated Cancer